These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28399113)

  • 21. 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.
    Horwitz KB; Sartorius CA
    J Mol Endocrinol; 2020 Jul; 65(1):T49-T63. PubMed ID: 32485679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients?
    Alimonti A; Ferretti G; Cognetti F
    J Clin Oncol; 2005 Dec; 23(34):8918; author reply 8918-9. PubMed ID: 16314657
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
    Walter V; Fischer C; Deutsch TM; Ersing C; Nees J; Schütz F; Fremd C; Grischke EM; Sinn P; Brucker SY; Schneeweiss A; Hartkopf AD; Wallwiener M
    Breast Cancer Res Treat; 2020 Aug; 183(1):137-144. PubMed ID: 32613540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to: Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'.
    Shin VY; Kwong A
    Br J Cancer; 2016 May; 114(10):e6. PubMed ID: 27100733
    [No Abstract]   [Full Text] [Related]  

  • 25. Mismatch between perfusion and metabolism in locally advanced breast cancer.
    Evangelista L; Cervino AR
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):803-4. PubMed ID: 25316297
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeted Combinations for Hormone Receptor-Positive Advanced Breast Cancer: Who Benefits?
    Johnston SR
    J Clin Oncol; 2016 Feb; 34(5):393-5. PubMed ID: 26700117
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
    Fan Y; Ding X; Xu B; Ma F; Yuan P; Wang J; Zhang P; Li Q; Luo Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2066. PubMed ID: 26579819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical demonstration of oestrogen and progesterone receptors.
    Cross SS
    J Clin Pathol; 2001 Jan; 54(1):78-9. PubMed ID: 11271797
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'.
    Ho-Yen C; Bowen RL; Kermorgant S; Jones JL
    Br J Cancer; 2013 May; 108(10):2195-6. PubMed ID: 23674084
    [No Abstract]   [Full Text] [Related]  

  • 30. Progesterone receptor and human epidermal growth factor receptor 2 status: an independent influence on the efficacy of endocrine therapy in breast cancer?
    Ponzone R; Maggiorotto F; Robba C; Fuso L; Sismondi P
    J Clin Oncol; 2006 Mar; 24(9):1481-2; author reply 1482. PubMed ID: 16549847
    [No Abstract]   [Full Text] [Related]  

  • 31. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of estrogen and progesterone receptors, HER2 protein and Ki-67 proliferation index in breast carcinoma in both tumor tissue and tissue microarray.
    Hacısalihoğlu UP; Dogan MA
    Biotech Histochem; 2022 May; 97(4):298-305. PubMed ID: 34519589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up.
    Lashen AG; Toss MS; Mongan NP; Green AR; Rakha EA
    Cancer; 2023 Apr; 129(8):1183-1194. PubMed ID: 36653923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
    Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
    J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast.
    Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
    Breast Cancer; 2004; 11(3):301-6. PubMed ID: 15550850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of O-linked glycosyltransferase GALNT7 in breast cancer is dependent on estrogen-, progesterone-, and HER2-receptor status, with prognostic implications.
    Berkel C; Cacan E
    Glycoconj J; 2023 Dec; 40(6):631-644. PubMed ID: 37947928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative?
    Bernstein L; Lacey JV
    J Natl Cancer Inst; 2011 Mar; 103(6):451-3. PubMed ID: 21346225
    [No Abstract]   [Full Text] [Related]  

  • 38. PGRMC1: a new biomarker for the estrogen receptor in breast cancer.
    Craven RJ
    Breast Cancer Res; 2008; 10(6):113. PubMed ID: 19090968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
    Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
    Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
    Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.